OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00086059

Kangnam Jevisco Co Ltd

Commodity ChemicalsVerified

Kangnam Jevisco's capital structure shows a debt-to-equity ratio of 0.19, indicating a relatively conservative leverage position. The company holds 50,059,481,880 KRW in cash and equivalents, but its free cash flow is negative at -4,275,819,740 KRW, suggesting operational cash flow is insufficient to cover capital expenditures. The current ratio of 1.51 implies the company can cover its short-term liabilities with its current assets, but the risk assessment flags net cash as negative after subtracting total debt. Profitability metrics are weak, with a return on equity of -0.43% and a return on assets of -0.28%. These figures fall below the typical thresholds for healthy performance in the Commodity Chemicals industry, where returns on equity and assets are usually positive and above 5% and 3%, respectively. The company's operating income of 6,869,746,290 KRW is significantly lower than its gross profit of 74,625,228,420 KRW, indicating high operating expenses or inefficiencies. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond the domestic Korean market. This lack of diversification increases exposure to local economic conditions and regulatory changes. No specific geographic breakdown is provided in the latest financial disclosures, but the company's operations are primarily within South Korea. Growth trajectory is mixed. The company's revenue in the latest period was 598,552,862,280 KRW, but net income is negative at -2,688,360,980 KRW. Analysts reported a last actual revenue of 315,787,400,000 KRW, which is significantly lower than the reported revenue, suggesting potential discrepancies or seasonal volatility. The outlook for the current fiscal year is uncertain, with no clear direction provided in the financial data. Risk factors include medium liquidity risk due to negative free cash flow and a low dilution risk, as the company has not issued additional shares recently. The risk assessment also notes that net cash is negative after subtracting total debt, which could limit the company's ability to fund operations or invest in growth without external financing. No dilution sources are identified in the latest filings, and the dilution potential is assessed as low. Recent events include the company's transition from Kunsul Chemical Industrial Co., Ltd to its current name, reflecting a strategic rebranding. No recent filings or transcripts are available in the provided data, but the company's financial performance suggests a need for operational improvements or cost reductions to achieve profitability. The company's debt levels and negative net income indicate a need for close monitoring of its financial health.

30-day price · 000860+740.00 (+5.2%)
Low$13470.00High$18170.00Close$14980.00As of22 May, 00:00 UTC
Profile
CompanyKangnam Jevisco Co Ltd
Ticker000860.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Kangnam Jevisco Co Ltd is a Korea-based company engaged in the manufacture of paints and coatings, including architectural coatings, industrial coatings, anti-corrosive coatings, and coatings for vehicles, machinery, and construction materials.

Classification. Kangnam Jevisco is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Kangnam Jevisco's capital structure shows a debt-to-equity ratio of 0.19, indicating a relatively conservative leverage position. The company holds 50,059,481,880 KRW in cash and equivalents, but its free cash flow is negative at -4,275,819,740 KRW, suggesting operational cash flow is insufficient to cover capital expenditures. The current ratio of 1.51 implies the company can cover its short-term liabilities with its current assets, but the risk assessment flags net cash as negative after subtracting total debt. Profitability metrics are weak, with a return on equity of -0.43% and a return on assets of -0.28%. These figures fall below the typical thresholds for healthy performance in the Commodity Chemicals industry, where returns on equity and assets are usually positive and above 5% and 3%, respectively. The company's operating income of 6,869,746,290 KRW is significantly lower than its gross profit of 74,625,228,420 KRW, indicating high operating expenses or inefficiencies. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond the domestic Korean market. This lack of diversification increases exposure to local economic conditions and regulatory changes. No specific geographic breakdown is provided in the latest financial disclosures, but the company's operations are primarily within South Korea. Growth trajectory is mixed. The company's revenue in the latest period was 598,552,862,280 KRW, but net income is negative at -2,688,360,980 KRW. Analysts reported a last actual revenue of 315,787,400,000 KRW, which is significantly lower than the reported revenue, suggesting potential discrepancies or seasonal volatility. The outlook for the current fiscal year is uncertain, with no clear direction provided in the financial data. Risk factors include medium liquidity risk due to negative free cash flow and a low dilution risk, as the company has not issued additional shares recently. The risk assessment also notes that net cash is negative after subtracting total debt, which could limit the company's ability to fund operations or invest in growth without external financing. No dilution sources are identified in the latest filings, and the dilution potential is assessed as low. Recent events include the company's transition from Kunsul Chemical Industrial Co., Ltd to its current name, reflecting a strategic rebranding. No recent filings or transcripts are available in the provided data, but the company's financial performance suggests a need for operational improvements or cost reductions to achieve profitability. The company's debt levels and negative net income indicate a need for close monitoring of its financial health.
Key takeaways
  • Kangnam Jevisco has a conservative debt-to-equity ratio of 0.19 but faces negative free cash flow and weak profitability.
  • The company's return on equity and return on assets are negative, indicating poor performance relative to industry norms.
  • Revenue is concentrated in a single business segment with no material geographic diversification.
  • The company's liquidity risk is medium, and its dilution risk is low, but net cash is negative after subtracting total debt.
  • Recent rebranding and lack of recent filings suggest a need for closer monitoring of operational and financial performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$598.55B
Gross profit$74.63B
Operating income$6.87B
Net income-$2.69B
R&D
SG&A
D&A
SBC
Operating cash flow$38.63B
CapEx-$28.02B
Free cash flow-$4.28B
Total assets$974.02B
Total liabilities$354.40B
Total equity$619.62B
Cash & equivalents$50.06B
Long-term debt$116.36B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$619.62B
Net cash-$66.30B
Current ratio1.5
Debt/Equity0.2
ROA-0.3%
ROE-0.4%
Cash conversion-14.4%
CapEx/Revenue-4.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000860Activity
Op margin1.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-0.4%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin12.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity19.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS676.00 KRW
Last actual revenue315,787,400,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 14:12 UTC#871bd49f
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 14:15 UTCJob: 52f181ed